Oura secured $75 million in funding led by Dexcom, increasing its valuation to $5.2 billion and paving the way for enhanced health tracking capabilities in wearables.

Target Information

Oura is an innovative health technology company that is transforming wellness through its state-of-the-art wearable rings. These advanced devices integrate seamless health tracking with a stylish and minimalist design, offering users the tools they need to optimize their overall well-being. The Oura Ring is designed to deliver comprehensive insights into various health metrics, including sleep quality, physical activity, and general health status.

Equipped with sophisticated sensors, the Oura Ring monitors essential metrics such as heart rate, heart rate variability, body temperature, and blood oxygen levels. By providing users with actionable data, the Oura Ring helps enhance both daily performance and long-term health.

Industry Overview in Finland

Finland has emerged as a leader in health technology, characterized by a robust ecosystem that fosters innovation and collaboration between startups, research institutions, and established corporations. Th

View Source

Similar Deals

Hammas Hohde Oy Hammasklinikka Kruunu Oy

2025

Other Hospitals, Clinics & Primary Care Services Finland
Terveystalo Recuror Oy

2025

Other Hospitals, Clinics & Primary Care Services Finland
PlusTerveys Hammasklinikat Oy Hyggan klinikkaliiketoiminta

2025

Other Hospitals, Clinics & Primary Care Services Finland
SpringWorks Therapeutics Rappta Therapeutics

2025

Other Bio Therapeutic Drugs Finland
Mehiläinen 9Lives Kotipalvelut Oy

2023

Other Home Healthcare Services Finland
Mikeva Nurmela Kodit

2016

Other Residential & Long-Term Care Finland

Dexcom

invested in

Oura

in 2022

in a Other deal

Disclosed details

Transaction Size: $75M

Enterprise Value: $5,200M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert